skip to Global Navigation Bar
skip to main content
HOME
CONTACT US
SITEMAP
KOREAN
Global Business
Introduction
Strategy
Manufacturing
Contact Us
R&D
Introduction
Global R&D Centers
R&D Organization
Pipeline
CDMO
Introduction
Manufacturing Sites
Business Model
Service Range
Products
Global Brand
Products Search
In-License
Introduction
Strategy
No.1 Position
Core-Competency
Licensed Products
Partnership
Investors
Management information
Financial information
Stock condition
IR information
About Us
Company Profile
CEO Message
Recruitment
Press Release
Company Profile
CEO Message
Recruitment
Press Release
News
PR Video
Home > About Us > Press Release >
News
뉴스
No
Subject
Data
215
Daewoong Pharmaceuticals proves fatigue recovery effect of Ursa through clinical trial
2016-04-18
214
Daewoong Pharmaceuticals announces US clinical trial result on Nabota at Dubai Derma and spurs exportation
2016-04-15
213
Daewoong Pharmaceuticals and AstraZeneca Korea jointly sell ‘Cresto’, treatment for hyperlipidemia
2016-04-11
212
Daewoong Pharmaceuticals announces the result of phase 3 clinical trial in US on Nabota
2016-04-08
211
Daewoong Pharmaceuticals signs export contract and MOU with Taiwanese and Malaysian pharmaceutical companies
2016-04-06
210
Daewoong Pharmaceuticals strengthens CP... Extends to the entire corporate group
2016-03-31
209
Daewoong Pharmaceuticals - Daiichi-Sankyo Korea Expect sales of 30 billion won this year with Sevikar HCT
2016-03-17
208
"Effective corporation in overseas markets" Distinguished export strategy by Daewoong Pharmaceuticals
2016-02-24
207
Erdos by Daewoong Pharmaceuticals expecting a blockbuster growth with its outstanding mucolytic effects for 2016
2016-02-22
206
Daewoong Pharmaceuticals’ Daewoong Meropenem Inj. US FDA approved
2016-01-05
1
/
2
/
3
/
4
/
5
/
6
/
7
/
8
/
9
/
10
/
News Search
subject
content
Home > About Us > Press Release > News
Home > About Us > Press Release > News